申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US04720493A1
公开(公告)日:1988-01-19
Thienylthiazole compounds of the formula: ##STR1## and pharmaceutically acceptable acid addition salts thereof, wherein: R is amino, guanidino, alkylamino, alkenylamino, unsubstituted or optionally substituted phenylamino or acylamino; A is amino, alkylamino, cyclic amino, alkanoylamino, a group of the formula: ##STR2## wherein each symbol is as defined in claim 1; Z is hydrogen or halogen; and m is 0 or 1 to 4, are useful in the treatment of peptic ulcer, acute or chronic gastritis, acute damage of gastric mucous membrane, dimentia and anxiety.
式子:## STR1 ## 的噻唑并噻唑烯化合物和药学上可接受的酸盐,其中:R是氨基,胍基,烷基氨基,烯基氨基,未取代或可选地取代的苯基氨基或酰基氨基; A是氨基,烷基氨基,环氨基,酰基氨基,式子:## STR2 ## 中的一种,其中每个符号如权利要求1所定义的; Z是氢或卤素; m为0或1至4,用于治疗消化性溃疡、急性或慢性胃炎、胃黏膜急性损伤、痴呆和焦虑症。